President Donald Trump on Thursday signed an executive order on the cryptocurrency industry, in a long-awaited move that ...
Stocks ended mostly higher Thursday, with the S&P 500 notching its first record finish since Dec. 6 -- and its first of President Donald Trump's second term. It didn't take much, the large-cap ...
Long-dated U.S. government debt sold off for a second session as President Donald Trump threatened to impose tariffs again and criticized the European Union for what he called an unequitable trade ...
Shares of Tiziana Life Sciences rose after the company said it received positive results from its nasal anti-CD3 monoclonal antibody in traumatic spinal cord injury. The stock was up 5.3% to 84 cents ...
Shares of Evolv Technologies climbed Thursday after the company disclosed it is cutting jobs to reduce cash expenses. The stock was up 22% to $2.92 in afternoon trading. Shares have dropped 16% over ...
A rip-roaring rally at the onset of President Donald Trump’s second term in office has brought the S&P 500 back to record territory, stretching market valuations to extremes. In turn, investors have w ...
Oil futures finished Thursday at their lowest in two weeks after President Donald Trump said he would ask Saudi Arabia and ...
U.S. President Donald Trump on Thursday proved that words can be just as powerful as actions, after his promise to ask the Saudis and OPEC to lower the cost of oil led to a downturn in crude prices.
After some two years of strong growth, Electronic Arts Inc.’s key soccer-gaming segment is struggling to keep up the momentum. And despite good reviews, its role-playing game “Dragon Age: The ...
Stocks extended their rally following Donald Trump's Nov. 5 presidential election victory — with gains tied to expectations for deregulation and other pro-growth policies — before losing steam in ...
President Donald Trump said he has issues with the European Union's treatment of the world's most powerful American companies, criticizing the bloc's multi-billion euro fines on Big Tech as a form of ...
AstraZeneca will invest 820 million Canadian dollars, equivalent to $570.3 million, to facilitate a move to a larger office in the Toronto metro area. The Anglo-Swedish pharmaceutical giant said ...